Macular Edema
Showing NaN - NaN of 11
Macular Edema, Branch Retinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Branch Retinal Vein Occlusion
- Faricimab
- +2 more
-
Phoenix, Arizona
- +151 more
Aug 4, 2022
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (suprachoroidal CLS-TA, suprachoroidal sham, IVT aflibercept)
Terminated
- Macular Edema
- Retinal Vein Occlusion
- suprachoroidal CLS-TA
- +2 more
-
Peoria, Arizona
- +109 more
Mar 18, 2021
Macular Edema Trial in Worldwide (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Edema
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Graz, Steiermark, Austria
- +63 more
Jul 15, 2020
Macular Edema, Retinal Vein Occlusion Trial in Worldwide (700 µg Dexamethasone, 350 µg Dexamethasone, Sham Injection)
Completed
- Macular Edema
- Retinal Vein Occlusion
- 700 µg Dexamethasone
- +2 more
-
Los Angeles, California
- +12 more
Apr 11, 2019
Macular Edema Trial in Worldwide (dexamethasone Intravitreal Implant, ranibizumab)
Completed
- Macular Edema
- dexamethasone Intravitreal Implant
- ranibizumab
-
Arlington, Texas
- +12 more
Apr 9, 2019
Macular Edema Trial in Worldwide (Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321))
Completed
- Macular Edema
- Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
-
Graz, Steiermark, Austria
- +75 more
Sep 12, 2018
Macular Edema, Central Retinal Vein Occlusion Trial in Worldwide (Ranibizumab 0.5 mg/0.05 ml)
Completed
- Macular Edema
- Central Retinal Vein Occlusion
- Ranibizumab 0.5 mg/0.05 ml
-
Parramatta, New South Wales, Australia
- +77 more
Sep 21, 2016
Function and Structure Imaging in Different Retinal Diseases:
Completed
- Diabetic Retinopathy
- +2 more
-
Coimbra, PortugalAIBILI
Feb 2, 2015